Acadia Pharmaceuticals Inc (ACAD) Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) FY 2026 Other Release

Newsdesk: